Hydrafil, an experimental injectable hydrogel appears to be safe and effective in reducing chronic lower back pain associated with degenerative disc disease.
Researchers have developed a new injectable gel that releases microRNAs into heart muscles, restarting the replication of existing caridomyocytes following a heart attack.
